Anti Infective Endotracheal Tube

Anti-Infective Endotracheal Tube Market Outlook

The global anti-infective endotracheal tube market is poised for significant growth, with an estimated market size of USD 1.5 billion in 2025 and a compound annual growth rate (CAGR) of approximately 8.5% over the forecast period of 2025 to 2035. This growth can be attributed to several factors, including the rising prevalence of respiratory diseases, increasing rates of hospitalization, and advancements in medical technology that enhance patient safety and comfort. The growing awareness among healthcare professionals regarding the importance of infection control in critical care settings also contributes to the market's expansion. Additionally, the ongoing research and development activities aimed at introducing innovative endotracheal tube designs are anticipated to fuel the demand significantly. The escalating incidence of acute respiratory distress syndrome (ARDS) and the need for effective ventilation solutions further drive the necessity for anti-infective endotracheal tubes.

Growth Factor of the Market

The anti-infective endotracheal tube market is witnessing growth due to several key factors that underscore its increasing relevance in modern healthcare. One of the most significant growth drivers is the rising incidence of respiratory illnesses, which necessitate mechanical ventilation and, consequently, the use of endotracheal tubes. As healthcare systems continue to adapt to the challenges posed by respiratory infections, including COVID-19, the demand for advanced endotracheal tube technologies has surged. Furthermore, the increasing number of critical care units and operating facilities is creating a higher need for effective airway management solutions, further supporting market growth. Innovations in materials used for endotracheal tubes, allowing for better biocompatibility and reduced infection risks, are also pivotal in propelling market advancements. Finally, the growing emphasis on patient safety and comfort during mechanical ventilation is encouraging healthcare facilities to invest in higher-quality anti-infective tubes, thus enhancing the overall market landscape.

Key Highlights of the Market

• Increasing prevalence of respiratory diseases driving demand for mechanical ventilation.
• Advancements in endotracheal tube technology enhancing patient safety and comfort.
• Growing number of critical care units and operating rooms requiring effective airway management solutions.
• Focus on infection control protocols in healthcare settings promoting anti-infective product adoption.
• Innovations in materials, such as hydrogel coatings, aimed at reducing infection risks.

By Product Type

Standard Endotracheal Tubes:

Standard endotracheal tubes represent a foundational product within the anti-infective endotracheal tube market. These are widely used in various clinical settings, particularly in emergency scenarios and routine intubation procedures. Their design allows for direct access to the trachea, facilitating effective ventilation. However, while they are critical tools, they are associated with certain infection risks, necessitating the development of anti-infective coatings to minimize potential complications. The simplicity and cost-effectiveness of standard tubes make them a preferred choice in many healthcare facilities, contributing to their significant market share.

Cuffed Endotracheal Tubes:

Cuffed endotracheal tubes have gained prominence in critical care due to their ability to provide a secure airway and reduce the risk of aspiration. The cuff is inflated to create a seal within the trachea, enhancing ventilation efficiency and ensuring that the delivered oxygen reaches the lungs effectively. This type of tube is particularly beneficial in patients who require prolonged mechanical ventilation, as it helps prevent respiratory complications associated with lung infections. The rising adoption of cuffed tubes in intensive care units supports their growth in the market, driven by the increasing emphasis on patient safety and infection control.

Preformed Endotracheal Tubes:

Preformed endotracheal tubes are specially designed to accommodate complex anatomical structures, making them particularly useful in surgeries that require specific positioning of the airway. Their pre-bent design allows for easier placement and reduces the time taken to secure an airway, which is vital in emergency situations. These tubes are often utilized in patients with known airway challenges, providing a tailored solution to enhance the efficiency of intubation procedures. Increasing awareness among anesthesiologists and emergency physicians about the advantages of preformed tubes is propelling their market growth.

Reinforced Endotracheal Tubes:

Reinforced endotracheal tubes are designed for situations where standard tubes may be susceptible to kinking or obstruction. These tubes have a spiral reinforcement that provides structural integrity, making them suitable for use in complex surgical procedures and patients with unique anatomical considerations. The use of reinforced tubes is particularly prevalent in neurosurgery and thoracic surgeries, where maintaining an open airway is crucial. The increasing complexity of surgeries and the demand for reliable airway management solutions continue to drive the adoption of reinforced endotracheal tubes in the market.

Double-Lumen Endotracheal Tubes:

Double-lumen endotracheal tubes are specifically designed for patients requiring independent lung ventilation, allowing for separate ventilation of each lung. This type of tube is frequently utilized in thoracic surgeries and critical care situations where unilateral lung function needs to be assessed or treated. The ability to isolate ventilation can enhance patient outcomes and reduce complications associated with traditional single-lumen tubes. As surgical techniques advance and the need for precise respiratory management increases, the double-lumen endotracheal tube market is expected to grow significantly in the coming years.

By Application

Intensive Care Units:

The application of anti-infective endotracheal tubes in intensive care units (ICUs) is critical, as these environments are often filled with patients who are critically ill and require mechanical ventilation. The use of anti-infective tubes in ICUs helps to minimize the risk of ventilator-associated pneumonia (VAP), a common complication in mechanically ventilated patients. With the increasing patient population in ICUs due to chronic respiratory conditions and acute infections, the demand for advanced endotracheal tubes tailored for infection control continues to rise, thereby propelling market growth.

Operating Rooms:

In operating rooms, anti-infective endotracheal tubes play an essential role in ensuring the safety and efficiency of anesthesia delivery. During surgical procedures, maintaining an open airway is crucial, and the use of anti-infective tubes minimizes the risk of infections that could arise during intubation. The growing number of surgical procedures performed globally, especially those requiring general anesthesia, drives the demand for these specialized tubes. Additionally, the focus on infection prevention during surgeries contributes to the increasing adoption of anti-infective endotracheal tubes in operating rooms.

Emergency Rooms:

The application of anti-infective endotracheal tubes in emergency rooms is vital for the management of patients experiencing respiratory failure or airway obstruction. In emergency situations, rapid intubation is often necessary, and the use of anti-infective tubes helps to mitigate the risk of infections that could complicate the patient's condition further. The rising incidence of respiratory emergencies, including acute respiratory distress syndrome (ARDS) and trauma cases, is anticipated to drive the demand for these tubes in emergency care settings, enhancing patient outcomes and safety.

Homecare Settings:

In homecare settings, the use of anti-infective endotracheal tubes is becoming increasingly relevant as more patients receive respiratory support at home. With the growing trend of hospital-at-home programs and an emphasis on patient-centered care, the availability of safe and effective airway management tools is crucial. Homecare providers prioritize infection control and patient comfort, leading to the adoption of anti-infective tubes designed for long-term use. As the population ages and the prevalence of chronic respiratory conditions increases, the demand for these specialized tubes in homecare environments is expected to grow significantly.

Others:

Other applications of anti-infective endotracheal tubes may include specialized care settings such as long-term rehabilitation centers and palliative care facilities. These environments often require tailored airway management solutions that prioritize infection control and patient comfort. The increasing recognition of the importance of effective ventilation in diverse healthcare settings is contributing to the growth of this segment. As healthcare providers seek to improve patient outcomes across various care environments, the demand for anti-infective endotracheal tubes is likely to expand in these alternative applications.

By Distribution Channel

Hospitals:

Hospitals serve as a primary distribution channel for anti-infective endotracheal tubes, given their critical role in acute care and emergency services. Hospitals utilize a substantial volume of these tubes in various departments, including surgery, intensive care, and emergency medicine. The continuous influx of patients requiring respiratory support contributes to the high demand for these specialized products. Furthermore, hospitals prioritize infection prevention protocols, driving the adoption of anti-infective endotracheal tubes to enhance patient safety and reduce healthcare-associated infections. The growing emphasis on patient care quality and infection control initiatives further solidifies hospitals' position as the leading distribution channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly important in the distribution of anti-infective endotracheal tubes, as these facilities perform a variety of surgical procedures on an outpatient basis. The ability to provide efficient anesthesia and airway management is crucial in ASCs, where patient safety and rapid recovery are prioritized. The demand for anti-infective endotracheal tubes in ASCs is driven by the growing trend towards outpatient surgeries, which reduces healthcare costs and enhances patient convenience. As these centers continue to expand, the market for anti-infective tubes is expected to witness steady growth.

Specialty Clinics:

Specialty clinics, which focus on specific medical areas such as pulmonology, anesthesiology, or critical care, also contribute to the distribution of anti-infective endotracheal tubes. These clinics often cater to patients with complex respiratory conditions requiring specialized airway management. The increasing prevalence of respiratory diseases and the need for targeted treatment approaches support the demand for high-quality anti-infective tubes in these settings. Additionally, the emphasis on personalized patient care and specialized interventions drives the adoption of these tubes in specialty clinics, ensuring optimized patient outcomes.

Online Stores:

Online stores represent a growing distribution channel for anti-infective endotracheal tubes, providing convenience and accessibility for healthcare providers and institutions. The rise of e-commerce in the medical supplies sector caters to the increasing demand for specialized products, allowing healthcare professionals to procure anti-infective tubes quickly and efficiently. Online platforms often provide detailed product information, comparisons, and customer reviews, enhancing the purchasing experience for buyers. As the trend toward digital procurement continues to evolve, online stores are expected to play a more significant role in the overall distribution of anti-infective endotracheal tubes.

Others:

Other distribution channels for anti-infective endotracheal tubes may include medical supply wholesalers, distributors, and direct sales through manufacturers. These channels play a crucial role in ensuring that healthcare facilities, clinics, and individual practitioners have access to the necessary equipment for effective airway management. The competitive landscape among distribution channels continues to evolve as manufacturers and suppliers seek innovative ways to reach their customers and address the growing demand for anti-infective solutions in healthcare settings. This diversification of distribution channels contributes to the overall growth and accessibility of anti-infective endotracheal tubes.

By Material Type

Polyvinyl Chloride:

Polyvinyl chloride (PVC) is one of the most commonly used materials for manufacturing anti-infective endotracheal tubes, owing to its favorable properties, including flexibility, strength, and resistance to various chemicals. PVC tubes are lightweight and cost-effective, making them a popular choice in hospitals and clinics. Additionally, advancements in PVC manufacturing techniques have led to the development of tubes with reduced toxicity and improved biocompatibility, enhancing patient safety. The widespread use of PVC in the healthcare industry is expected to drive the demand for these tubes, especially in environments where cost considerations are paramount.

Silicone:

Silicone endotracheal tubes are gaining traction in the market due to their biocompatibility and resistance to heat and chemical degradation. These tubes are particularly beneficial for long-term intubation, as they are less likely to cause irritation to the tracheal mucosa, reducing the risk of complications associated with prolonged use. The soft and flexible nature of silicone tubes allows for better patient comfort, making them suitable for use in intensive care settings. As healthcare providers increasingly prioritize patient outcomes and comfort, the demand for silicone anti-infective endotracheal tubes is expected to rise.

Polyurethane:

Polyurethane endotracheal tubes offer several advantages over traditional materials, including enhanced biocompatibility and reduced risk of infection. These tubes are often designed with anti-infective coatings that provide a barrier against microbial colonization, further enhancing patient safety. Polyurethane tubes are also known for their durability and resistance to kinking, making them suitable for a variety of clinical applications. The growing focus on infection control and the need for effective airway management solutions are driving the adoption of polyurethane anti-infective endotracheal tubes in hospitals and other healthcare settings.

Others:

The "Others" category encompasses various alternative materials and innovations in endotracheal tube manufacturing. This includes the use of composite materials that combine the advantages of different polymers, leading to enhanced performance characteristics. Emerging technologies such as antimicrobial coatings and biodegradable materials are also being explored to address the growing concerns related to infection control and environmental sustainability in healthcare. As research and development efforts continue to evolve, these alternative materials are expected to carve out a niche in the anti-infective endotracheal tube market.

By Region

The regional analysis of the anti-infective endotracheal tube market reveals distinct trends and growth opportunities across various geographical areas. North America holds the largest share of the market, accounting for approximately 40% of the total revenue in 2025. The dominance of this region can be attributed to the presence of advanced healthcare infrastructure, high levels of healthcare spending, and increasing awareness of infection control protocols in hospitals. Furthermore, the rapid adoption of innovative technologies and a growing elderly population in North America are expected to drive market growth at a CAGR of 9.0% from 2025 to 2035.

Europe follows North America closely, capturing around 30% of the market share in 2025. The European market is primarily driven by the rising prevalence of respiratory diseases and the increasing number of surgical procedures performed across the region. Countries such as Germany, France, and the UK are at the forefront of adopting advanced medical technologies, including anti-infective endotracheal tubes. The Asia Pacific region is also emerging as a significant market player, accounting for approximately 20% of the global share. Factors such as rapid urbanization, improving healthcare infrastructure, and rising awareness of infection prevention are contributing to the growth of the anti-infective endotracheal tube market in this region.

Opportunities

The anti-infective endotracheal tube market presents numerous opportunities for growth, particularly in emerging economies where healthcare systems are evolving rapidly. The expansion of healthcare facilities and the increasing focus on improving patient care standards are driving the demand for advanced medical devices, including anti-infective endotracheal tubes. As countries invest in modernizing their healthcare infrastructure, the need for effective airway management solutions will become increasingly critical. Additionally, the rise of telemedicine and homecare services opens new avenues for distributing anti-infective endotracheal tubes, allowing patients to receive high-quality care while minimizing the risk of infections.

Another significant opportunity lies in the innovation and development of next-generation anti-infective endotracheal tubes. The incorporation of advanced technologies, such as antimicrobial coatings and smart monitoring systems, can enhance patient safety and optimize respiratory management. Healthcare providers are increasingly seeking solutions that not only prevent infections but also provide real-time data on patient status during intubation. As manufacturers focus on research and development to address these needs, the anti-infective endotracheal tube market is expected to witness substantial growth driven by innovation and technological advancements.

Threats

Despite the promising growth prospects of the anti-infective endotracheal tube market, several threats could impede its progress. One of the primary concerns is the potential for regulatory challenges and stringent approval processes associated with new medical devices. The rigorous regulations imposed by health authorities may delay the introduction of innovative products into the market, hindering growth. Additionally, the increasing competition among manufacturers can lead to price wars, potentially impacting profit margins and market stability. Furthermore, the ongoing changes in healthcare policies and reimbursement structures could create uncertainty in the market, making it difficult for companies to predict demand and plan their strategies effectively.

A significant threat to the market also stems from the potential for product recalls and safety concerns. Instances of adverse events or product failures can significantly damage the reputation of manufacturers and lead to a loss of consumer trust. As healthcare providers become more vigilant about infection control, any negative publicity surrounding anti-infective endotracheal tubes could deter their adoption. Finally, the emergence of alternative airway management solutions may pose a challenge to the market, as healthcare providers explore various options to address their patients' needs.

Competitor Outlook

• Medtronic plc
• Teleflex Incorporated
• Boston Scientific Corporation
• Smiths Medical, Inc.
• Halyard Health, Inc.
• ConvaTec Group plc
• Fisher & Paykel Healthcare Limited
• Abbott Laboratories
• Vyaire Medical, Inc.
• B. Braun Melsungen AG
• Cook Medical, Inc.
• AngioDynamics, Inc.
• Medline Industries, Inc.
• Geuder AG
• Intersurgical Ltd.

The competitive landscape of the anti-infective endotracheal tube market is characterized by a diverse range of players, each vying for a significant share of the market. Established companies like Medtronic and Teleflex dominate the landscape, leveraging their extensive experience and innovation capabilities to introduce advanced products. These companies invest heavily in research and development to enhance the performance and safety of their endotracheal tubes, ensuring that they meet the evolving needs of healthcare providers. Additionally, the presence of numerous regional players further intensifies competition, as they seek to capture market opportunities by offering cost-effective solutions and localized services.

In recent years, there has been a notable trend toward mergers and acquisitions within the anti-infective endotracheal tube market. Companies are seeking to strengthen their market positions and expand their product portfolios through strategic partnerships. This trend is expected to continue as players aim to innovate and introduce advanced technologies to address the growing demand for infection control in airway management. The collaboration between manufacturers and healthcare providers is also becoming increasingly essential, as companies seek to gather insights and feedback on product performance in clinical settings, driving further improvements in endotracheal tube design and functionality.

Major companies such as Boston Scientific and Halyard Health are also exploring new opportunities in emerging markets, where the demand for healthcare solutions is on the rise. These companies are focused on expanding their footprint in regions such as Asia Pacific and Latin America, where increased investments in healthcare infrastructure are creating a favorable environment for growth. Additionally, players are prioritizing sustainability and the development of environmentally friendly products, which could enhance their market appeal and resonate with healthcare providers and patients alike. As the anti-infective endotracheal tube market continues to evolve, understanding the competitive dynamics and emerging trends will be crucial for stakeholders aiming to succeed in this promising landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Geuder AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ConvaTec Group plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Intersurgical Ltd.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AngioDynamics, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Halyard Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Smiths Medical, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Vyaire Medical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B. Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Teleflex Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medline Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fisher & Paykel Healthcare Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Anti Infective Endotracheal Tube Market, By Application
    • 6.1.1 Intensive Care Units
    • 6.1.2 Operating Rooms
    • 6.1.3 Emergency Rooms
    • 6.1.4 Homecare Settings
    • 6.1.5 Others
  • 6.2 Anti Infective Endotracheal Tube Market, By Product Type
    • 6.2.1 Standard Endotracheal Tubes
    • 6.2.2 Cuffed Endotracheal Tubes
    • 6.2.3 Preformed Endotracheal Tubes
    • 6.2.4 Reinforced Endotracheal Tubes
    • 6.2.5 Double-Lumen Endotracheal Tubes
  • 6.3 Anti Infective Endotracheal Tube Market, By Material Type
    • 6.3.1 Polyvinyl Chloride
    • 6.3.2 Silicone
    • 6.3.3 Polyurethane
    • 6.3.4 Others
  • 6.4 Anti Infective Endotracheal Tube Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Anti Infective Endotracheal Tube Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Anti Infective Endotracheal Tube market is categorized based on

By Product Type

• Standard Endotracheal Tubes
• Cuffed Endotracheal Tubes
• Preformed Endotracheal Tubes
• Reinforced Endotracheal Tubes
• Double-Lumen Endotracheal Tubes

By Application

• Intensive Care Units
• Operating Rooms
• Emergency Rooms
• Homecare Settings
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Stores
• Others

By Material Type

• Polyvinyl Chloride
• Silicone
• Polyurethane
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Teleflex Incorporated
• Boston Scientific Corporation
• Smiths Medical, Inc.
• Halyard Health, Inc.
• ConvaTec Group plc
• Fisher & Paykel Healthcare Limited
• Abbott Laboratories
• Vyaire Medical, Inc.
• B. Braun Melsungen AG
• Cook Medical, Inc.
• AngioDynamics, Inc.
• Medline Industries, Inc.
• Geuder AG
• Intersurgical Ltd.